Cautious Interpretation of the Association Between Topical Corticosteroid Exposure and Type 2 Diabetes

Clicks: 20
ID: 329311
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #135 of 411 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 411 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Kim et al.'s cohort study on topical corticosteroids (TCS) and incident type 2 diabetes raises three methodological concerns. First, enrollment in 2012 with diabetes ascertainment from 2017 creates a five-year window when outcomes cannot occur, underestimating absolute risk. Second, exposure metrics are redundant (duration derived from prescriptions) and potency groups are pooled; a prescription-count gradient is needed. Third, propensity matching on age and sex ignores disease severity, explaining the spurious protective effect of low-potency TCS; an active comparator within a single indication is recommended.
Reference Key
openalex_W7213870382 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag416
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.